Sodium phosphates and Loraz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sodium phosphates (sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous) and Loraz (lorazepam). Common drug interactions include platelet count decreased among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Sodium phosphates and Loraz. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Sodium phosphates?

Sodium phosphates has active ingredients of sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous. eHealthMe is studying from 154 Sodium phosphates users. Check the latest studies of Sodium phosphates.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

On Jul, 26, 2026

18 people who take Sodium phosphates and Loraz together, and have interactions are studied.

Sodium phosphates and Loraz drug interactions.

What are the common drug interactions of Sodium Phosphates and Loraz, by gender? *:

female:

Platelet count decreased
Culture urine positive
Nausea (feeling of having an urge to vomit)
Pleural effusion (water on the lungs)
Thrombocytopenia (decrease of platelets in blood)
Vomiting
Abdominal discomfort
Abdominal pain
Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
Agitation (state of anxiety or nervous excitement)

male:

Confusional state
Depressed level of consciousness
Fall
Hepatic failure (liver failure)
Hypovolaemic shock (shock caused by severe blood or fluid loss)
Neutropenia (an abnormally low number of neutrophils)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Renal failure (kidney dysfunction)
Reticulocytosis (a condition where there is an increase in reticulocytes)
Thrombocytopenia (decrease of platelets in blood)

What are the common drug interactions of Sodium Phosphates and Loraz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Abdominal discomfort
Abdominal pain
Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
Alopecia (absence of hair from areas of the body)
Ascites (accumulation of fluid in the abdominal cavity)
Back pain
Blood albumin decreased
Blood phosphorus decreased
Blood phosphorus increased
Bone pain

20-29:

n/a

30-39:

International normalised ratio increased

40-49:

Platelet count decreased
Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
Blood creatinine increased
Cardiac ventricular disorder (ventricular dysfunction of heart)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Conduction disorder (serious disorder of the heart not responses proper to impulses)
Constipation
Culture urine positive
Diarrhoea
Dyspnoea (difficult or laboured respiration)

50-59:

Activated partial thromboplastin time prolonged
Agitation (state of anxiety or nervous excitement)
Hallucination (an experience involving the perception of something not present)
International normalised ratio increased
Neutropenia (an abnormally low number of neutrophils)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pulmonary haemorrhage (acute bleeding from the lung)
Reticulocytosis (a condition where there is an increase in reticulocytes)
Thrombocytopenia (decrease of platelets in blood)

60+:

Confusional state
Depressed level of consciousness
Hepatic failure (liver failure)
Hypovolaemic shock (shock caused by severe blood or fluid loss)
Platelet count decreased
Renal failure (kidney dysfunction)
Thrombocytopenia (decrease of platelets in blood)
Respiratory failure (inadequate gas exchange by the respiratory system)
Trismus (reduced opening of the jaws)
Constipation

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 3 people, 16.67%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 16.67%
Psychomotor Hyperactivity (feelings of extreme restlessness): 2 people, 11.11%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 11.11%
Staphylococcal Bacteraemia (a bacterial infection of blood): 1 person, 5.56%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 5.56%
Renal Cell Carcinoma Stage Unspecified (kidney cancer in unknown stage): 1 person, 5.56%
Procedural Pain: 1 person, 5.56%
Haemorrhage (bleeding): 1 person, 5.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Sodium phosphates and Loraz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously